Transaction in Own Shares • May 11, 2023
Transaction in Own Shares
Open in ViewerOpens in native device viewer
| Summary Info | Share buy back transactions dated 11.05.2023 |
| Update Notification Flag | Yes |
| Correction Notification Flag | No |
| Postponed Notification Flag | No |
| Company Performs the Buy-Back | BİOTREND ÇEVRE VE ENERJİ YATIRIMLARI A.Ş. |
| Company Subject to Buy-Back | BİOTREND ÇEVRE VE ENERJİ YATIRIMLARI A.Ş. |
| Type Of Buy-Back | Other |
| The Purpose of Buy-Back | As the share price does not reflect the actual performance of our Company's activities, to protect the shareholders and to ensure its performance reflect share prices real value. |
| Board Decision Date | 14.02.2023 |
| Number Of Shares To Be Acquired | 5.000.000 |
| Maximum Amount To Be Paid (TL) | 100.000.000 |
Details of Buy-Back
| Code of Share Subject to Buy-back | Transaction Date | Nominal Value of Shares Subject to Transaction (TRY) | Ratio To Capital (%) | Transaction Price (TRY / Unit) | Privileges, If Any, Associated With These Shares |
| BIOEN, TREBION00012 | 15.02.2023 | 100.000 | 0 | 15,329 | - |
| BIOEN, TREBION00012 | 16.02.2023 | 200.000 | 0 | 14,304 | - |
| BIOEN, TREBION00012 | 11.05.2023 | 139.853 | 0 | 13,872 | - |
Additional Explanations
Within the scope of the share buyback decision initiated with the decision of our Company's Board of Directors dated 14.02.2023, our company bought back shares with a nominal value of 139,853 TL from the price range of 13.75 -14.00 TL per share (average 13,8716 TL) in Borsa Istanbul on 11.05.2023.
As a result of the transactions performed today, the nominal value of our Company's shares has reached 439,853 TL, and the ratio of repurchased shares to the capital has reached %0.09. Transactions were added to the detail table of buyback transactions.
Respectfully bringing the attention of public.
In contradiction between the Turkish and English versions of this public disclosure, the Turkish version shall prevail.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.